The consensus view is that Coca-Cola's price/mix engine has run its course. The data on emerging markets, away-from-home channel recovery, and the Fairlife premium portfolio says the next leg has barely started.
The consensus view on Coca-Cola is that the four-year pricing-led growth cycle (which delivered approximately 11% organic growth annually through fiscal 2022 to 2024) has plateaued. The thesis says: revenue growth normalises to 4-5%, operating margin holds, the multiple compresses from 24x to 21x as growth converges with peers. We disagree.
The Valuation Desk reads the data differently. The pricing power Coca-Cola exhibits is not the cyclical inflation pricing the consensus credits; it is structural mix shift toward higher-margin products and emerging market premiumisation that has approximately three years of runway remaining. The fiscal 2025 print, which the consensus dismissed as a single quarter of strong execution, is the leading edge of a multi-year mix shift that the consensus model is missing.
The contrarian thesis: Coca-Cola is in the early stage of a structural margin expansion, not at the end of a pricing cycle. The five percentage points of operating margin expansion since fiscal 2022 (from 24.7% to 28.7%) is being read by the consensus as a peak; we read it as the midpoint of an expansion toward 32-34%. The mechanism is in the segment-level data.
The consensus framework treats Coca-Cola as a mature consumer staples business with limited unit volume growth and pricing capped by the discretionary cushion of consumers in developed markets. The framework was correct for the 2010-2020 period. It is wrong for the current cycle.
Three structural changes invalidate the consensus framework. First, the away-from-home channel (restaurants, stadiums, cinemas, vending) has continued to recover post-pandemic, with Coca-Cola's away-from-home volume still approximately 8% below the fiscal 2019 baseline. The away-from-home channel is materially higher margin than at-home (approximately 200 basis points of incremental gross margin per unit). The recovery to baseline alone contributes 20-25 basis points of consolidated margin expansion annually for the next three years.
Second, the Fairlife premium portfolio (acquired in 2020) has scaled to approximately $3 billion of revenue and is the fastest-growing brand in the consolidated portfolio, growing at approximately 20-25% annually. The brand's gross margin is approximately 200 basis points above the company average. Fairlife's contribution to consolidated mix is approximately 40-50 basis points of incremental margin annually as it scales.
Third, emerging market premiumisation. Coca-Cola's portfolio in India, China, and Sub-Saharan Africa has been actively shifted toward higher-margin formats (smaller pack sizes at higher per-millilitre price points, premium variants such as Coke Zero and Sprite Lemon-Lime). The mix shift in emerging markets contributes approximately 80 basis points of price/mix annually that the consensus has been treating as cyclical inflation pricing.
TickerXray Report
Get the complete Coca-Cola report with all 12 quantitative models, AI-generated investment thesis, and real-time data.
Concern one is that GLP-1 drug adoption will compress carbonated beverage volumes. The argument is that semaglutide-class drugs reduce caloric appetite and that Coca-Cola's volume base is exposed. The data, three years into widespread GLP-1 adoption in the US, shows approximately 0.5-1% drag on category volume in the affected demographic (40-65 year olds in higher income brackets). The drag is real but small relative to the offsetting tailwinds: Gen Z volume growth, away-from-home recovery, and emerging market expansion. The consensus has weighted the GLP-1 risk at approximately 3-4% volume drag through 2028; the data supports approximately 1% drag.
Concern two is that emerging market currency weakness compresses dollar-reported revenue growth. The Argentine peso, Turkish lira, and Nigerian naira have all weakened against the US dollar over the last 24 months. The currency effect is real, but Coca-Cola's franchise model (where bottling partners take currency exposure) means that the corporate-level economics are reasonably hedged. Operating margin in the affected markets has compressed less than 50 basis points despite local currency moves of 30-50%.
Concern three is that the Costa Coffee acquisition has underperformed deal economics. The concern is fair on absolute returns. Costa has not delivered the synergy capture management committed to at acquisition. The financial impact, however, is small (Costa contributes approximately 2% of consolidated revenue and approximately 1% of operating income). The concern is, frankly, more about management credibility on M&A than about the consolidated economics.
Coca-Cola's gross margin in fiscal 2025 was 61.6%, the highest figure in 15 years. Operating margin of 28.7% is the highest since fiscal 2010. The expansion has been steady: 24.7% in 2022, 24.8% in 2023, 21.2% (one-time charge depressed) in 2024, 28.7% in 2025. The five-year trajectory is upward.
The segment-level decomposition of the margin expansion shows: approximately 80 basis points from price/mix in developed markets (which is, frankly, slowing as the consensus correctly identifies); approximately 120 basis points from emerging market premiumisation (the structural component the consensus is missing); approximately 60 basis points from Fairlife scaling; approximately 40 basis points from away-from-home recovery; approximately 100 basis points from operating expense leverage on growing revenue. The total expansion mechanism is dominantly structural, not cyclical.
The forward earnings power, on conservative assumptions, is approximately $3.50 EPS in fiscal 2026 and $3.85 in fiscal 2027. The consensus EPS for fiscal 2027 is approximately $3.50. The 10% gap on consensus is the contrarian setup; if the operating margin expansion continues at the trajectory implied by the segment data, EPS exceeds consensus by 8-12% over the forward two years. Multiple expansion is layered on top.
Free cash flow has been temporarily compressed by working capital changes and litigation-related cash outflows. The fiscal 2025 free cash flow of $5.3 billion is below the run-rate generation power of approximately $9-10 billion annually. The litigation overhang is finite (the IRS tax case has been resolved with the cash impact largely flowing through the next 12-18 months). Free cash flow normalisation alone supports approximately 25-30% multiple expansion if the consensus catches up to the operating trajectory.
The consensus view that Coca-Cola's pricing power has plateaued is contradicted by the segment-level data. The structural mix shift toward higher-margin emerging markets, the Fairlife premium portfolio, and the away-from-home recovery collectively support approximately 200 basis points of additional operating margin expansion over the next 36 months. The consensus EPS for fiscal 2027 is approximately 10% below the trajectory implied by the operating data. Fair value at $86 against the current $78 quote, with potential to $95 if the operating margin expansion continues at the fiscal 2025 cadence. Bullish, with conviction. The historical pattern with consumer staples companies that compound mid-single-digit organic growth and high-single-digit operating profit growth is that the multiple expands by 1-2 points over the cycle. The same dynamic applied to Procter & Gamble between 2017 and 2020. We are buyers below $80.
Full forensic analysis of Coca-Cola
+ 6 more models included
150,000+ stocks covered
Global coverage across 60+ exchanges. Every report includes all 12 quantitative models and AI analysis.
View plansEvery report runs 12 quantitative models and generates an AI investment thesis. From Piotroski scores to manipulation detection -- get the full picture in seconds.
12 forensic models
Piotroski, Altman, Beneish, DuPont & more
AI investment thesis
Synthesized outlook on every stock
Manipulation detection
Spot red flags before they hit the news
150,000+ tickers
Global coverage across 60+ exchanges
Expected return
Forward return projections for every stock
Real-time data
Live prices, insider trades, news sentiment
Free accounts get 1 report per month. Pro gets unlimited.
The capital allocation framework that Warren Buffett endorsed for 37 years has produced 5.8% per-share dividend growth compounded. The analytical take on whether the framework still fits.
The dividend headlines treat KO as a slow-growth defensive. The 38% jump in operating income, the Marriott commercial win, and the fairlife capacity expansion tell a different story.
Coca-Cola's 27% margins and 25%+ ROIC versus P&G's lower valuation and broader diversification. A head-to-head comparison of capital allocation quality in consumer staples.